膳食纤维菊粉联合降甲状旁腺激素治疗改善CKD-MBD大鼠骨重塑与力学性能
该研究在CKD-MBD(Cy/+)大鼠模型中,将膳食纤维菊粉与PTH抑制方案(KP-2326或2%钙)联用,观察骨结构、骨重塑、力学性能及血清标志物。结果显示菊粉联合KP-2326降低皮质骨孔隙率和骨小梁转换,并改善力学性能;菊粉联合钙则使骨转换低于健康对照。提示膳食纤维联合拟钙剂可能减轻CKD伴甲状旁腺功能亢进时的骨骼恶化。
要点
- 菊粉联合KP-2326较单药降低皮质骨孔隙率并改善骨力学性能
- 菊粉联合KP-2326降低骨小梁转换,优于任一单药
- 菊粉联合2%钙使骨转换低于健康对照水平
核心结论
- 膳食纤维菊粉联合拟钙剂KP-2326可改善CKD-MBD大鼠的骨重塑与力学性能,支持该联合策略用于减轻CKD伴甲状旁腺功能亢进时的骨骼恶化。
研究设计与样本
- 采用CKD-MBD动物模型(Cy/+大鼠),设置菊粉与PTH抑制 agents(KP-2326或2%钙)的联合干预,评估骨结构、骨重塑、力学性能及血清标志物。
主要发现
- 菊粉组循环尿毒症毒素p-甲酚硫酸盐水平降低,丁酸水平升高。
- 菊粉联合KP-2326组的皮质骨孔隙率低于未治疗组。
- 菊粉联合KP-2326组的骨小梁转换低于未治疗组,且优于任一单药治疗。
- 菊粉联合KP-2326组力学性能改善。
- 菊粉联合2%钙组骨转换低于健康对照水平。
临床怎么用
- 在CKD伴甲状旁腺功能亢进患者中,可考虑膳食纤维联合拟钙剂以改善骨重塑与力学性能,但需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Chronic kidney disease (CKD) has devastating effects on the skeletal system, resulting in an increased fracture risk. CKD results in the buildup of metabolites in the blood (often referred to as uremic toxins), and several uremic toxins have been linked to adverse skeletal outcomes. We have shown that dietary fiber inulin reduced uremic toxins and had a positive effect on bone. Here, we determine whether combining inulin with parathyroid hormone (PTH)-lowering therapies could improve skeletal properties beyond either therapy alone. METHODS: An animal model of CKD-mineral bone disorder (CKD-MBD) (Cy/+ rats) was treated with or without inulin in the presence or absence of the PTH-suppressing agents (KP-2326, an analogue of the calcimimetic etelcalcetide, or 2% calcium). Key outcome measures included bone architecture, bone remodeling, mechanical properties and serum biomarkers. RESULTS: Dietary inulin groups had lower circulating levels of the uremic toxin p-cresol sulfate and higher circulating butyrate levels, indicating diet-induced differences in gut-derived metabolites. Combining inulin with KP-2326 resulted in lower cortical bone porosity than that in untreated animals and lower trabecular bone turnover (relative to untreated animals) than did either treatment alone. Combining inulin with KP-2326 led to improved mechanical properties. Combining inulin with calcium treatment suppressed bone turnover below healthy control levels. CONCLUSIONS: The improvement in bone remodeling and mechanical properties speaks favorably for combining dietary fiber intervention with calcimimetics for reducing the skeletal deterioration in CKD with hyperparathyroidism.
引用
- Allen MR, Metzger CE, Chen NX, et al. Combining dietary fiber inulin with parathyroid hormone-lowering therapy improves bone remodeling and mechanics in a rat model of Chronic Kidney Disease-Mineral Bone Disorder. Kidney Int. 2026. PMID: 42612870. doi:10.1016/j.kint.2026.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。